Ani Pharmaceuticals ANIP
NASDAQ ANIP
$77.32 -0.70 (-0.90%)
At close: Aug 20, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Return on Equity (2021 - 2023)

Ani Pharmaceuticals (ANIP) posted Return on Equity of 0.0% for Q1 2023, up 45.25% sequentially from 0.0% in Q4 2022, and little changed YoY from 0.0% in Q1 2022.

Ani Pharmaceuticals (ANIP) Return on Equity (2021 - 2023) Analysis & Trends

Ani Pharmaceuticals has reported Return on Equity for 3 years, with the latest figure at 0.0% in Q1 2023.

  • Quarterly Return on Equity changed 0.0% year-over-year to 0.0% in Q1 2023, while the trailing twelve-month figure through Mar 2023 was 0.0% (changed 0.0% YoY) and the FY2022 annual result came in at 0.0%, changed 0.0% from the prior year.
  • Return on Equity improved to 0.0% in Q1 2023 per ANIP's latest filing, from 0.0% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q1 2023 and troughed at 0.0% in Q3 2022.
  • A 3-year average of 0.0% and a median of 0.0% in 2021 frame the typical range for Return on Equity.
  • The widest YoY moves for Return on Equity: up 0 bps in 2022, down 0 bps in 2022.
  • Over 3 years, Return on Equity stood at 0.0% in 2021, then climbed by 8 bps to 0.0% in 2022, then jumped by 45 bps to 0.0% in 2023.
  • According to Business Quant data, Return on Equity over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2023, Q4 2022, and Q3 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Return on Equity (Quarter)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Ani Pharmaceuticals 1.64 Bn 1.28 Bn 165.89 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 0.00%
Dec 31, 2022 0.00%
Sep 30, 2022 0.00%
Jun 30, 2022 0.00%
Mar 31, 2022 0.00%
Dec 31, 2021 0.00%
Sep 30, 2021 0.00%